Arrowhead Pharmaceuticals saw the highest growth of 1.13% in patent filings in April and 1.49% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 1.13% and grants by 0.28%. GlobalData’s DataBook provides a comprehensive analysis of Arrowhead Pharmaceuticals‘s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Arrowhead Pharmaceuticals has been focused on protecting inventions in Japan(JP) with five publications in Q2 2024
The Japan(JP) Patent Office dominates the patent filings and grants with nearly 10% filings and 38% grants. The World Intellectual Property Organization(WIPO), Australia(AU), European Patent Office(EPO), and Japan(JP) patent Office are among the top ten patent offices where Arrowhead Pharmaceuticals is filings its patents. Among the top granted patent authorities, Arrowhead Pharmaceuticals has 38% of its grants in Japan(JP), 38% in Israel(IL) and 12% in Australia(AU).
Novo Nordisk Foundation could be the strongest competitor for Arrowhead Pharmaceuticals
In terms of grant share, Arrowhead Pharmaceuticals stands first among its competitors followed by Arrowhead Pharmaceuticals and Novo Nordisk Foundation.
Patents related to rare diseases and climate change lead Arrowhead Pharmaceuticals's portfolio
Arrowhead Pharmaceuticals has the highest number of patents in rare diseases followed by, climate change. For rare diseases, nearly 89% of patents were filed and 50% of patents were granted in Q2 2024.
Pulmonary inflammation related patents lead Arrowhead Pharmaceuticals portfolio followed by asthma, and fibrosis
Arrowhead Pharmaceuticals has highest number of patents in pulmonary inflammation followed by asthma, fibrosis, idiopathic pulmonary fibrosis, and lung disease.
For comprehensive analysis of Arrowhead Pharmaceuticals's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
